<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Du K</submitter><funding>The College Students’ innovation and entrepreneurship training program of Lanzhou University</funding><funding>the Key Research and Development Program of Gansu Province</funding><funding>the Technological Innovation Guidance Program of Gansu Province</funding><funding>the Key Program for International S&amp;amp;T Cooperation Projects of China Gansu Province</funding><pagination>1212-1226</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9037217</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(1)</volume><pubmed_abstract>A series of novel derivatives of isaindigotone, which comes from the root of &lt;i>isaits indinatca&lt;/i> Fort, were synthesised (Compound &lt;b>1&lt;/b>-&lt;b>26&lt;/b>). Four human gastrointestinal cancer cells (HCT116, PANC-1, SMMC-7721, and AGS) were employed to evaluate the anti-proliferative activity. Among them, Compound &lt;b>6&lt;/b> displayed the most effective inhibitory activity on AGS cells with an IC&lt;sub>50&lt;/sub> (50% inhibitory concentration) value of 2.2 μM. The potential mechanism study suggested that Compound &lt;b&gt;6&lt;/b> induced apoptosis in AGS cells. The collapse of mitochondrial membrane potential (MMP) in AGS cells was proved. In docking analysis, good affinity interaction between Compound &lt;b>6&lt;/b> and AKT1 was discovered. Treatment of AGS cells with Compound &lt;b>6&lt;/b> also resulted in signific</pubmed_abstract><journal>Journal of enzyme inhibition and medicinal chemistry</journal><pubmed_title>Design, synthesis, and cytotoxic activities of isaindigotone derivatives as potential anti-gastric cancer agents.</pubmed_title><pmcid>PMC9037217</pmcid><funding_grant_id>18YF1WA115</funding_grant_id><funding_grant_id>21CX6QA127</funding_grant_id><funding_grant_id>21YF5FA112</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Hu S</pubmed_authors><pubmed_authors>Chen P</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Zhu H</pubmed_authors><pubmed_authors>Yang C</pubmed_authors><pubmed_authors>Ma W</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Tian Y</pubmed_authors><pubmed_authors>Jiang X</pubmed_authors><pubmed_authors>Du K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, synthesis, and cytotoxic activities of isaindigotone derivatives as potential anti-gastric cancer agents.</name><description>A series of novel derivatives of isaindigotone, which comes from the root of &lt;i>isaits indinatca&lt;/i> Fort, were synthesised (Compound &lt;b>1&lt;/b>-&lt;b>26&lt;/b>). Four human gastrointestinal cancer cells (HCT116, PANC-1, SMMC-7721, and AGS) were employed to evaluate the anti-proliferative activity. Among them, Compound &lt;b>6&lt;/b> displayed the most effective inhibitory activity on AGS cells with an IC&lt;sub>50&lt;/sub> (50% inhibitory concentration) value of 2.2 μM. The potential mechanism study suggested that Compound &lt;b&gt;6&lt;/b> induced apoptosis in AGS cells. The collapse of mitochondrial membrane potential (MMP) in AGS cells was proved. In docking analysis, good affinity interaction between Compound &lt;b>6&lt;/b> and AKT1 was discovered. Treatment of AGS cells with Compound &lt;b>6&lt;/b> also resulted in signific</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-05-30T15:48:26.915Z</modification><creation>2025-04-04T10:02:33.573Z</creation></dates><accession>S-EPMC9037217</accession><cross_references><pubmed>35450499</pubmed><doi>10.1080/14756366.2022.2065672</doi></cross_references></HashMap>